previous arrow
next arrow

MaxQ AI is ushering in a new era of AI-augmented healthcare through a comprehensive, seamless, and secure suite of patient-level medical diagnostic solutions. We aim to empower care providers around the world to better prioritize life-threatening conditions, such as stroke and head trauma in acute care settings. These solutions will help across the diagnosis, prognosis, and therapeutic pathways; potentially saving lives, improving the quality of care, and lowering healthcare costs.

Our Mission

Our mission is to reinvent patient diagnosis through artificial intelligence (AI), improved triaging and diagnostics processes, and reduction of avoidable medical errors and costs —all leading to better patient outcomes.

Our Focus

Stroke and head trauma are two areas where MaxQ AI has initially focused. The statistics are staggering. Stroke is the second leading cause of death globally and the number three cause of disability in the US with someone experiencing a stroke every 40 seconds, nearly 3.6 million people per year*.

Our Technology

MaxQ AI’s software suite is being designed to comprise several AI applications branded under the name ACCIPIO (meaning “to learn” in Latin). ACCIPIO uses artificial intelligence for the comprehensive, seamless, and secure assessment of non-contrast head CT for intracranial hemorrhage (ICH) prioritization, triage, annotation, quantification, and rule-out.

Delivering A New Class Of Medial Diagnostic Artificial Intelligence, Striving To:

Enhance escalation and intervention confidence.

Improve care quality, and lower healthcare costs.

Deployed through major CT, Radiology Reporting, AI platform, and PACS channel partners.

Greatly increase ICH detection and reduce missed ICHs through near real-time triage, annotation, and diagnostic rule-out.

Provide the right care readied faster, improving quality to potentially avoid poor patient outcomes and to decrease costs and liability.

Every Patient Deserves Equal Access
To Expert Care


Johns Hopkins investigators have estimated that medical errors are the #3 cause of death in the U.S. with 250,000 such deaths per year*.

Misdiagnosis, in general, may account for 40,000–80,000 preventable deaths annually in US hospitals*.

To compound this issue further, the Association of American Medical Colleges recently predicted the nationwide shortage of providers will reach up to 121,000 physicians by 2035*.

The economic impact? With the cost of stroke care estimated as $150,000 per year per patient, projections of $240 billion in total direct and indirect costs are anticipated*.

Stroke And Head Trauma

Data from the Target Stroke initiative suggests that for every 15-minute reduction in time to treatment, 3.2% more patients are able to ambulate, and 5.1% more patients are able to return home*.

Hospital admissions for intracerebral hemorrhage have increased by 18% in the past 10 years*.

Every 9 seconds, someone in the United States, sustains a brain injury*.

Rapoport Law Offices, P.C., announced that it has reached a $2.625 million settlement for the family of a 41-year-old woman who died as a result of medical malpractice and an undiagnosed brain bleed*.

find a partner
learn more
schedule demo

Blackford Analysis & MaxQ AI Webinar

Improving the Workflow for Head Trauma and Stroke Care Patients

Meet our Partners Series: MaxQ AI – Improving the Workflow for Head Trauma and Stroke Care Patients with Dr. Ajay Choudhri. Moderated by Conrad Chin, Chief Product Officer at Blackford, and Steve Kohlmyer, VP Research & Collaborations at MaxQ AI.

Accipio Dxg

Triage aid for case-level identification of suspected Intracranial hemorrhage positive finding or absence of ICH

Provides automatic, rapid, highly accurate triage for suspected ICH presence or high NPV absence.

Accipio Ix

Intracranial hemorrhage identification & prioritization

Provides automatic, rapid, highly accurate identification and prioritization of suspected ICH.

Accipio Ax

Intracranial hemorrhage slice-level annotation

Provides automatic, rapid, highly accurate slice-level annotation & prioritization of suspected ICH.

Accipio Ax Plus

Intracranial hemorrhage lesion-level annotation

Provides automatic, rapid, highly accurate lesion-level annotation of suspected ICH.

Channel Partners / Market Approach

MaxQ AI partners with AI industry-leading and trusted CT OEMs, PACS software, and AI Ecosystem companies
– including GE Healthcare (CT and PACS), IBM Watson, Philips (CT and PACS), FujiFilm, TeraRecon, Nuance, Blackford, Samsung Neurologica –
to distribute our integrated solutions through their worldwide channels. We strive to achieve global reach with our innovative imaging technologies and its deep clinical insights.

More About Accipio Clinical Suite

MaxQ AI will support the complete Accipio Clinical Suite with INSIGHT. It will support the Radiology Department, Emergency Room, Neuroradiology, and the Stroke teams with a fully automated solution.


Provides highly accurate auto-processing of the DICOM adult non-contrast head CT images with suspected ICH using artificial intelligence for prioritization and triage of intracranial hemorrhage.


Auto-returns rapid case-level summary report of a suspected intracranial hemorrhage to any DICOM compliant CT terminal or PACS worklist, informing if a suspected hemorrhage has been detected.


Zero clicks to ACCIPIO results. Zero need to leave workflow. Zero stored PHI. Zero change to original series. No onsite IT integration required. Seamless from the Start.


Class II FDA Cleared medical device, CE Marked, TGA approved, IMOH approved. ISO 13485 certified manufacturer. GDPR compliant. Supports HIPAA compliance. ISO 27001 Information Management Security Certified.


Maximum flexibility, rapidly deployed on major OEM CT and PACS, on-premises, and cloud-capable design. Able to grow with your CT and PACS.


MaxQ AI is at the forefront of transforming healthcare by empowering physicians to provide “smarter care” through intelligent imaging with actionable insights. We are committed to harnessing the power of artificial intelligence (AI) to raise the level of acute care in hospitals all around the world. We strive to deliver expert results to the physicians that save lives, improve care quality, and lower healthcare costs.

find a partner
learn more
schedule demo

Key Takeaways



Healthcare today is under a level of pressure that is unprecedented. To address this growing problem, MaxQ AI’s team of AI, deep learning, and machine vision experts have developed a revolutionary software suite capable of concurrently considering medical imaging, along with other data.



At MaxQ AI, we have developed a comprehensive workflow software suite, ACCIPIO (meaning “to learn” in Latin), that uses artificial intelligence to interpret medical images, such as non-contrast head computed tomography (CT) scans and surrounding patient data.



MaxQ AI’s partners distribute our comprehensive AI suite as part of their integrated solutions through their worldwide channels seamlessly to the physician, with “no clicks”, fully secure and supported. GE Healthcare (CT and PACS), IBM Watson Healthcare, Philips (CT and PACS), FujiFilm, TeraRecon, Nuance, Blackford Analysis, and Samsung Neurologica.



We prioritize absolute rigor in all certifications, systems, security, and compliance to ensure the company behind the suite leads by example.

  • FDA Breakthrough Status, Class II FDA Cleared and IMOH Approved, Class IIb CE Marked and TGA Approved
  • ISO13485, FDA QSR, ISO14971, IEC62304, IEC62366 Standards Certified
  • GDPR Compliant
  • Supports HIPAA Compliance
  • ISO 27001 Information Management Security System Certification
  • Data truthing by board-certified physicians
  • FDA Pre-Certification Member